Do not share your Fiasp® with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
When to consider NovoLog®
Millions of people with both type 1 and type 2 diabetes have taken NovoLog® to help reach their A1C goals since 2001. Ask your health care provider if NovoLog® is an option for you.
NovoLog® may be used by a broad range of patients
NovoLog® is a rapid-acting mealtime insulin that helps lower mealtime blood sugar spikes. It has been proven to help control high blood sugar in people with diabetes when taken with a long-acting insulin.
Pediatric patients
NovoLog® is approved for type 1 diabetes in children as young as 2 years of age.
Insulin pump users
NovoLog® is approved for use in insulin pumps in children aged 2 and older with type 1 diabetes and adults with diabetes. View device options ›
NovoLog® is usually prescribed as part of a basal-bolus therapy
Basal-bolus insulin therapy uses 2 types of insulin to more closely mimic the body’s normal insulin release. Basal-bolus insulin therapy is recommended for people with type 1 diabetes and for people with type 2 diabetes who need more blood sugar control than basal insulin alone can provide. Learn more about these 2 types of therapy ›